Binding peptides specific for the extracellular domain of ErbB2 and uses therefor
US7098302B2 · kind B2 · utility
18Cited by
10References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2002 |
| Grant date | Aug 29, 2006 |
| Priority date | — |
| Expiry date | May 30, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions for diagnosing and treating subjects using EBPs. Specifically disclosed are peptides and peptidomimetics that bind selectively to the extracellular domain of ErbB2. These compositions are useful in the prevention and treatment of disorders characterized by ErbB2 overexpression (e.g., breast cancer).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.